Detecting Grouped Local Average Treatment Effects and Selecting True Instruments
Nicolas Apfel, Helmut Farbmacher, Rebecca Groh, Martin Huber, Henrika, Langen

TL;DR
This paper introduces a two-step data-driven method to identify true instruments and homogeneous local average treatment effects in models with multiple, potentially invalid instruments, improving causal inference accuracy.
Contribution
It proposes a novel clustering-based procedure to distinguish valid instruments from invalid ones and consistently estimate homogeneous treatment effects despite instrument heterogeneity.
Findings
The method accurately identifies true instruments in simulations.
It provides consistent and asymptotically normal LATE estimators.
Empirical application shows effectiveness in real-world data.
Abstract
Under an endogenous binary treatment with heterogeneous effects and multiple instruments, we propose a two-step procedure for identifying complier groups with identical local average treatment effects (LATE) despite relying on distinct instruments, even if several instruments violate the identifying assumptions. We use the fact that the LATE is homogeneous for instruments which (i) satisfy the LATE assumptions (instrument validity and treatment monotonicity in the instrument) and (ii) generate identical complier groups in terms of treatment propensities given the respective instruments. We propose a two-step procedure, where we first cluster the propensity scores in the first step and find groups of IVs with the same reduced form parameters in the second step. Under the plurality assumption that within each set of instruments with identical treatment propensities, instruments truly…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Health Systems, Economic Evaluations, Quality of Life · Healthcare Policy and Management
